Search
Patexia Research
Case number 1:24-cv-00053

Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc. > Summary

Court Case Number 1:24-cv-00053

Filing Date May 17, 2024

Court West Virginia Northern District Court

Status Unknown

Appeal2024-1965

Related Patents

Doc No Title Issue date
11788102 CHO integration sites and uses thereof Oct 17, 2023
11769597 Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF Sep 26, 2023
11753459 Anti-VEGF protein compositions and methods for producing the same Sep 12, 2023
11732024 VEGF antagonist formulations suitable for intravitreal administration Aug 22, 2023
11707506 Use of a VEGF antagonist to treat angiogenic eye disorders Jul 25, 2023
11559564 Use of a VEGF antagonist to treat angiogenic eye disorders Jan 24, 2023
11555176 Cell culture medium for eukaryotic cells Jan 17, 2023
11525833 Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysis Dec 13, 2022
11505593 Anti-VEGF protein compositions and methods for producing the same Nov 22, 2022
11332771 Serum-free cell culture medium May 17, 2022
11312936 Taurine supplemented cell culture medium and methods of use Apr 26, 2022
11253572 Use of a VEGF antagonist to treat angiogenic eye disorders Feb 22, 2022
11084865 VEGF antagonist formulations suitable for intravitreal administration Aug 10, 2021
11066458 VEGF antagonist formulations suitable for intravitreal administration Jul 20, 2021
10927342 Taurine supplemented cell culture medium and methods of use Feb 23, 2021
10888601 Use of a VEGF antagonist to treat angiogenic eye disorders Jan 12, 2021
10828345 Use of a VEGF antagonist to treat angiogenic eye disorders Nov 10, 2020
10669594 Compositions and methods for detecting a biological contaminant Jun 2, 2020
10415055 Enhanced expression and stability regions Sep 17, 2019
10130681 Use of a VEGF antagonist to treat angiogenic eye disorders Nov 20, 2018
09816110 CHO integration sites and uses thereof Nov 14, 2017
09315281 System and methods for use in dispensing biopharmaceutical materials Apr 19, 2016
09254338 Use of a VEGF antagonist to treat angiogenic eye disorders Feb 9, 2016
09222106 Enhanced expression and stability regions Dec 29, 2015
Menu